S. Keady

563 total citations
26 papers, 409 citations indexed

About

S. Keady is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Immunology. According to data from OpenAlex, S. Keady has authored 26 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 7 papers in Economics and Econometrics and 7 papers in Immunology. Recurrent topics in S. Keady's work include Pharmaceutical studies and practices (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Biosimilars and Bioanalytical Methods (7 papers). S. Keady is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Biosimilars and Bioanalytical Methods (7 papers). S. Keady collaborates with scholars based in United Kingdom, Switzerland and India. S. Keady's co-authors include Alastair Sutcliffe, Ian Chi Kei Wong, Catherine Tuleu, Kendal Pitt, Felicity Smith, Kevin Taylor, Mohd Alsaleh, Robert Heuschkel, Simon Murch and J A Walker‐Smith and has published in prestigious journals such as PEDIATRICS, Alimentary Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

S. Keady

22 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Keady United Kingdom 10 184 90 78 59 57 26 409
Chris Corbett United Kingdom 14 32 0.2× 70 0.8× 254 3.3× 29 0.5× 4 0.1× 27 746
Ellen Berni United Kingdom 10 26 0.1× 15 0.2× 82 1.1× 34 0.6× 7 0.1× 32 431
Youngmee Ahn South Korea 11 151 0.8× 11 0.1× 28 0.4× 15 0.3× 3 0.1× 32 392
Judy Williams United States 13 57 0.3× 21 0.2× 76 1.0× 5 0.1× 3 0.1× 15 718
James D. Acton United States 13 56 0.3× 11 0.1× 108 1.4× 9 0.2× 2 0.0× 22 622
Naunihal Virdi United States 9 13 0.1× 42 0.5× 37 0.5× 134 2.3× 7 0.1× 20 316
C. Moriarty Australia 10 32 0.2× 11 0.1× 66 0.8× 8 0.1× 6 0.1× 20 838
Harvey Marcovitch United Kingdom 10 80 0.4× 24 0.3× 76 1.0× 19 0.3× 41 423
Elpis Hatziagorou Greece 13 53 0.3× 13 0.1× 70 0.9× 24 0.4× 1 0.0× 89 731
Terri A. Slagle United States 12 292 1.6× 16 0.2× 88 1.1× 23 0.4× 2 0.0× 17 591

Countries citing papers authored by S. Keady

Since Specialization
Citations

This map shows the geographic impact of S. Keady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Keady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Keady more than expected).

Fields of papers citing papers by S. Keady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Keady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Keady. The network helps show where S. Keady may publish in the future.

Co-authorship network of co-authors of S. Keady

This figure shows the co-authorship network connecting the top 25 collaborators of S. Keady. A scholar is included among the top collaborators of S. Keady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Keady. S. Keady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hariprasad, Seenu M., Frank G. Holz, Carl V. Asche, et al.. (2025). Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review. Ophthalmology and Therapy. 14(4). 621–641. 1 indexed citations
2.
3.
Pemberton‐Ross, Peter, et al.. (2020). PBI10 Cost Effectiveness Analysis for the Treatment of Psoriasis: The Use of Adalimumab Biosimilars. Value in Health. 23. S411–S412. 1 indexed citations
4.
5.
6.
7.
8.
9.
Gray, Nicola J., S. Keady, & J. E. R. McDonagh. (2010). Care in juvenile idiopathic arthritis. 285(7630). 655–658. 1 indexed citations
10.
Alsaleh, Mohd, Felicity Smith, S. Keady, & Kevin Taylor. (2009). Insulin pumps: from inception to the present and toward the future. Journal of Clinical Pharmacy and Therapeutics. 35(2). 127–138. 65 indexed citations
11.
Standing, Joseph F., et al.. (2009). Prospective observational study of adverse drug reactions to diclofenac in children. British Journal of Clinical Pharmacology. 68(2). 243–251. 15 indexed citations
12.
Smith, Felicity, Kevin Taylor, Jennifer Newbould, & S. Keady. (2008). Medicines for chronic illness at school: experiences and concerns of young people and their parents. Journal of Clinical Pharmacy and Therapeutics. 33(5). 537–544. 18 indexed citations
13.
Keady, S., et al.. (2008). National Patient Safety Agency: Improving patient safety across all critical care areas. Intensive and Critical Care Nursing. 24(2). 137–140. 4 indexed citations
14.
Keady, S.. (2007). Update on drugs for gastro-oesophageal reflux disease. Archives of Disease in Childhood Education & Practice. 92(4). ep114–ep118. 11 indexed citations
15.
Afzal, Nadeem, et al.. (2007). Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease. Digestive Diseases and Sciences. 52(12). 3329–3333. 22 indexed citations
16.
Keady, S., et al.. (2007). Rasburicase in the prevention and treatment of tumour lysis syndrome. Intensive and Critical Care Nursing. 24(1). 59–62. 6 indexed citations
17.
Keady, S., et al.. (2005). Voriconazole in the treatment of invasive fungal infections. Intensive and Critical Care Nursing. 21(6). 370–373. 11 indexed citations
18.
Keady, S., et al.. (2005). Ibuprofen in the management of neonatal Patent Ductus Arteriosus. Intensive and Critical Care Nursing. 21(1). 56–58. 7 indexed citations
19.
Keady, S., et al.. (2005). Caspofungin in the treatment of invasive fungal infections. Intensive and Critical Care Nursing. 22(1). 59–62. 2 indexed citations
20.
Dick, Andrew D., S. Keady, Mary Thomson, et al.. (2003). Use of unlicensed and off‐label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK. Alimentary Pharmacology & Therapeutics. 17(4). 571–575. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Corbett Breakdown of academic impact, for papers by Ellen Berni Breakdown of academic impact, for papers by Youngmee Ahn Breakdown of academic impact, for papers by Judy Williams Breakdown of academic impact, for papers by James D. Acton Breakdown of academic impact, for papers by Naunihal Virdi Breakdown of academic impact, for papers by C. Moriarty Breakdown of academic impact, for papers by Harvey Marcovitch Breakdown of academic impact, for papers by Elpis Hatziagorou Breakdown of academic impact, for papers by Terri A. Slagle
Rankless by CCL
2026